485 top medical experts on Chagas Disease across 44 countries and 38 U.S. states, including 340 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Chagas Disease: Infection with the protozoan parasite trypanosoma cruzi, a form of trypanosomiasis endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of parasympathetic ganglia; chagas cardiomyopathy; and dysfunction of the esophagus or colon.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Trypanosomiasis (2,461), Vector Borne Diseases (1,099) and Narrower Categories: Chagas Cardiomyopathy (923).
  4. Clinical Trials ClinicalTrials.gov : at least 62 including 1 Active, 40 Completed, 8 Recruiting
  5. Synonyms: South American Trypanosomiasis


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Schijman, Alejandro Gabriel   Google Publications
    Laboratorio de Biología Molecular de la Enfermedad de Chagas, Instituto de Ingeniería Genética y Biología Molecular Dr Héctor Torres INGEBI, Buenos Aires, Argentina. Electronic address: .
    Scientist  Highly Cited  Highly Published  Clinical Trial  Case Reports  Review 
    Subjects: Trypanosoma cruzi; Trypanocidal Agents; DNA, Protozoan; Nitroimidazoles; Real-Time Polymerase Chain Reaction
    Categories: Parasitology; Methods; Genetics; Therapeutic Use; Diagnosis; Drug Therapy
    The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications. (2012)
    Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial. (2018)

  2. Gascon, Joaquim   Google Publications
    Barcelona Institute for Global Health ISGlobal, Hospital Clínic- Universitat de Barcelona, Barcelona, Spain.
    Scientist  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports  Review 
    Relevant US NIH Grant Funding: $4,849,356 over the last 5 years
    Subjects: Trypanosoma cruzi; Nitroimidazoles; Trypanocidal Agents; Antibodies, Protozoan; Antiprotozoal Agents
    Categories: Diagnosis; Drug Therapy; Methods; Therapeutic Use; Blood; Administration & Dosage
    Chagas disease in Spain, the United States and other non-endemic countries. (2010)
    Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial. (2018)

  3. Meymandi, Sheba K   Cardiovascular Disease   ClinicalTrials.gov Google Publications
    Center of Excellence for Chagas Disease at Olive View-UCLA Medical Center, Sylmar, California.
    Physician  Highly Cited  Highly Published 
    Disclosed payments in 2021 from 3 biomedical companies, totalling $61.96, including $32.5 from  Abbott Laboratories
    Subjects: Drug-Related Side Effects and Adverse Reactions; Cardiomyopathies; Emigrants and Immigrants; Trypanocidal Agents; COVID-19
    Categories: Epidemiology; Adverse Effects; Diagnosis; Economics; Drug Therapy; Immunology
    An unfolding tragedy of Chagas disease in North America. (2013)
    Prevalence of Chagas Disease in the Latin American-born Population of Los Angeles. (2017)

  4. Bern, Caryn   Google Publications
    University of California in San Francisco, San Francisco, California.
    Scientist  Highly Cited  Highly Published  Clinical Trial 
    Subjects: Trypanosoma cruzi; Parasitemia; Antibodies, Protozoan; Insect Vectors; Triatoma
    Categories: Diagnosis; Blood; Epidemiology; Immunology; Methods; Transmission
    Trypanosoma cruzi and Chagas' Disease in the United States. (2011)
    Chagas disease in Spain, the United States and other non-endemic countries. (2010)

  5. Sosa-Estani, Sergio   ClinicalTrials.gov Google Publications
    Drugs for Neglected Diseases initiative DNDi, Rio de Janeiro, Brazil.
    Scientist  Highly Cited  Highly Published  Clinical Trial  Review 
    Subjects: Trypanosoma cruzi; Trypanocidal Agents; Nitroimidazoles; Pregnancy Complications, Parasitic; Infectious Disease Transmission, Vertical
    Categories: Therapeutic Use; Drug Therapy; Diagnosis; Epidemiology; Prevention & Control; Administration & Dosage
    Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial. (2017)
    New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial. (2021)

  6. Maguire, James H   Infectious Disease  Google Publications
    Division of Infectious Disease, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts, United States of America. Top Hospital
    Physician 
    Medical school: Harvard Medical School (MD, 1974)
    Medicare Accepted
    Disclosed payments from biomedical company (NuVasive, Inc.) in 2021 for $13.85
    Subjects: Nitroimidazoles; Trypanocidal Agents; Autonomic Nervous System; Autonomic Nervous System Diseases; Insect Control
    Categories: Parasitology; Physiopathology; Supply & Distribution; Therapeutic Use; Complications; Drug Therapy
    Chagas Disease in the United States: a Public Health Approach. (2019)
    Access to Chagas disease treatment in the United States after the regulatory approval of benznidazole. (2020)

  7. Torrico, Faustino     ClinicalTrials.gov Google Publications
    Fundación CEADES, Cochabamba, Bolivia.
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Review 
    Relevant US NIH Grant Funding: $4,849,356 over the last 5 years
    Subjects: Nitroimidazoles; Trypanosoma cruzi; Antiprotozoal Agents; DNA, Protozoan; Triazoles
    Categories: Methods; Drug Therapy; Diagnosis; Administration & Dosage; Blood; Therapeutic Use
    Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial. (2018)
    New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial. (2021)

  8. Weiss, Louis M   Infectious Disease   Google Publications
    Department of Pathology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY, 10461, USA. . Top Hospital
    Physician  Highly Cited  Highly Published 
    Subjects: Trypanosoma cruzi; Adipose Tissue, White; Docosahexaenoic Acids; Host-Pathogen Interactions; Adipocytes
    Categories: Metabolism; Immunology; Parasitology; Pathogenicity; Pathology; Physiology
    Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease. (2012)
    Mechanisms of Trypanosoma cruzi persistence in Chagas disease. (2012)

  9. Bowman, Natalie M   Internal Medicine   Google Publications
    Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA. Top Hospital
    Physician  Review 
    Relevant US NIH Grant Funding: $1,588,576 over the last 5 years
    Subjects: Pregnancy Complications, Parasitic; Trypanosoma cruzi; Autonomic Nervous System Diseases; HIV Infections; Infectious Disease Transmission, Vertical
    Categories: Diagnosis; Complications; Transmission; Immunology; Isolation & Purification; Physiopathology
    Hindgut microbiota in laboratory-reared and wild Triatoma infestans. (2019)
    Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients. (2016)

  10. Traina, Mahmoud M   Internal Medicine   Google Publications
    Center of Excellence for Chagas Disease, Olive View-UCLA Medical Center. Sylmar, California, USA.
    Physician 
    Subjects: Drug-Related Side Effects and Adverse Reactions; Emigrants and Immigrants; Trypanocidal Agents; Hispanic or Latino; Nitroimidazoles
    Categories: Adverse Effects; Epidemiology; Drug Therapy; Ethnology; Etiology; Complications
    Prevalence of Chagas Disease in the Latin American-born Population of Los Angeles. (2017)
    Safety Profile of Nifurtimox for Treatment of Chagas Disease in the United States. (2016)

  11. Sanchez, Daniel R   Internal Medicine  Google Publications
    Center of Excellence for Chagas Disease, Olive View-UCLA Medical Center Sylmar, CA, United States of America.
    Physician 
    Disclosed payments from biomedical company (Novo Nordisk Inc) in 2021 for $23.75
    Subjects: Drug-Related Side Effects and Adverse Reactions; Emigrants and Immigrants; Cardiomyopathies; Health Knowledge, Attitudes, Practice; Hispanic or Latino
    Categories: Adverse Effects; Epidemiology; Ethnology; Drug Therapy; Etiology; Physiopathology
    Safety Profile of Nifurtimox for Treatment of Chagas Disease in the United States. (2016)
    Prevalence and Impact of Chagas Disease Among Latin American Immigrants With Nonischemic Cardiomyopathy in Los Angeles, California. (2015)

  12. Dumonteil, Eric O   Google Publications
    Department of Tropical Medicine, School of Public Health and Tropical Medicine, and Vector-Borne and Infectious Disease Research Center, Tulane University, New Orleans, LA, USA.
    Scientist  Highly Cited  Highly Published  Clinical Trial  Review 
    Subjects: Trypanosoma cruzi; Triatoma; Protozoan Vaccines; Insect Vectors; Antibodies, Protozoan
    Categories: Immunology; Parasitology; Prevention & Control; Transmission; Epidemiology; Genetics
    Chagas disease: the new HIV/AIDS of the Americas. (2012)
    Deep sequencing reveals multiclonality and new discrete typing units of Trypanosoma cruzi in rodents from the southern United States. (2020)

  13. Herrera, Claudia P   Pediatrics   Google Publications
    Department of Tropical Medicine, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA.
    Physician  Highly Cited  Highly Published  Clinical Trial  Review 
    Relevant US NIH Grant Funding: $1,501,282 over the last 5 years
    Disclosed payments in 2021 from 37 biomedical companies, totalling $774.62, including $186.56 from  Takeda Pharmaceuticals U.S.A., Inc.
    Subjects: Trypanosoma cruzi; Genetic Variation; Disease Reservoirs; Disease Transmission, Infectious; Exons
    Categories: Parasitology; Genetics; Epidemiology; Veterinary; Prevention & Control; Transmission
    Deep sequencing reveals multiclonality and new discrete typing units of Trypanosoma cruzi in rodents from the southern United States. (2020)
    Interactions among Triatoma sanguisuga blood feeding sources, gut microbiota and Trypanosoma cruzi diversity in southern Louisiana. (2020)

  14. Edwards, Morven S   Pediatric Infectious Diseases  Google Publications
    Department of Pediatrics, Baylor College of Medicine, Houston, Texas. Top Hospital
    Physician 
    Subjects: Pregnancy Complications, Parasitic; Infectious Disease Transmission, Vertical; Trypanosoma cruzi
    Categories: Diagnosis; Epidemiology; Congenital
    Chagas disease: the new HIV/AIDS of the Americas. (2012)
    Neglected parasitic infections in the United States: Chagas disease. (2014)

  15. Gilman, Robert H   Plastic Surgery  Google Publications
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
    Physician  Highly Cited  Highly Published  Clinical Trial  Review 
    Relevant US NIH Grant Funding: $9,348,902 over the last 5 years
    Medical school: Boston University School of Medicine (MD, 1974)
    Medicare Accepted
    Subjects: Trypanosoma cruzi; Antigens, Protozoan; Parasitemia; Antibodies, Protozoan; Infectious Disease Transmission, Vertical
    Categories: Immunology; Blood; Diagnosis; Epidemiology; Methods; Transmission
    Epidemiology of and impact of insecticide spraying on Chagas disease in communities in the Bolivian Chaco. (2013)
    Toward Improving Early Diagnosis of Congenital Chagas Disease in an Endemic Setting. (2017)

  16. Ribeiro, Isabela   ClinicalTrials.gov Google Publications
    Drugs for Neglected Diseases initiative DNDi, Geneva, Switzerland.
    Scientist  Highly Cited  Highly Published  Clinical Trial  Review 
    Subjects: Trypanosoma cruzi; Nitroimidazoles; Trypanocidal Agents; Real-Time Polymerase Chain Reaction; Triazoles
    Categories: Drug Therapy; Methods; Therapeutic Use; Administration & Dosage; Parasitology; Blood
    Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial. (2018)
    New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial. (2021)

  17. Molina, Israel     ClinicalTrials.gov Google Publications
    Barcelona Institute for Global Health IS Global, Barcelona, Spain.
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports  Review 
    Subjects: Nitroimidazoles; Trypanocidal Agents; Trypanosoma cruzi; Triazoles; Nifurtimox
    Categories: Therapeutic Use; Drug Therapy; Diagnosis; Blood; Genetics; Administration & Dosage
    Randomized trial of posaconazole and benznidazole for chronic Chagas' disease. (2014)
    Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial. (2017)

  18. Hoft, Daniel Fredric   Infectious Disease   Google Publications
    Division of Infectious Diseases, Allergy and Immunology, Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri, USA.
    Physician 
    Relevant US NIH Grant Funding: $416,625 over the last 5 years
    Medicare MIPS (Merit-based Incentive Payment System) rating: 70/100
    Subjects: Trypanosoma cruzi; Protozoan Vaccines; Gastric Mucosa; Glycoproteins; Immunity, Mucosal
    Categories: Immunology; Prevention & Control; Administration & Dosage; Metabolism; Parasitology; Physiology
    Th17 Cells Are More Protective Than Th1 Cells Against the Intracellular Parasite Trypanosoma cruzi. (2016)
    Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi. (2011)

  19. Murphy, Philip M   Infectious Disease   Google Publications
    Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases NIAID , Bethesda, MD, USA.
    Physician 
    Relevant US NIH Grant Funding: $2,643,230 over the last 5 years
    Subjects: Interleukin-10; Myocarditis; Trypanosoma cruzi; Vasculitis; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
    Categories: Parasitology; Pathology; Prevention & Control; Immunology; Physiology; Therapeutic Use
    IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection. (2012)
    Trypanosoma cruzi Causes Paralyzing Systemic Necrotizing Vasculitis Driven by Pathogen-Specific Type I Immunity in Mice. (2016)

  20. Rossmann, Susan N   Blood Banking & Transfusion Medicine  Google Publications
    Gulf Coast Regional Blood Center, Houston, TX, USA.
    Physician  Case Reports 
    Disclosed payments from biomedical company (Dendreon Pharmaceuticals LLC) in 2021 for $32.12
    Subjects: Blood Donors; Trypanosoma cruzi; Insect Vectors; Mass Screening; Risk Assessment
    Categories: Diagnosis; Epidemiology; Isolation & Purification; Methods; Parasitology; Physiology
    Evidence of autochthonous Chagas disease in southeastern Texas. (2015)
    Likely Autochthonous Transmission of Trypanosoma cruzi to Humans, South Central Texas, USA. (2017)

Note:
  1. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);